A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: The Snap-02 Italian Collaborative Study

Annals of Oncology

Volumn 20, Issue 4, 2009, Pages 660-665

  Lissoni, A A ^a   Colombo, N ^b   Pellegrino, A ^a   Parma, G ^b   Zola, P ^c   Katsaros, D ^d   Chiari, S ^a   Buda, A ^a   Landoni, F ^b   Peiretti, M ^b   Dell'Anna, T ^a   Fruscio, R ^a   Signorelli, M ^a   Grassi, R ^e   Floriani, I ^f   Fossati, R ^f   Torri, V ^f   Rulli, E ^f  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c MAURIZIANO HOSPITAL   (Italy)

^d POLITECNICO DI TORINO   (Italy)

^e TREVIGLIO HOSPITAL   (Italy)

^f MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Cisplatin; Ifosfamide; Locally advanced cervical carcinoma; Neo adjuvant chemotherapy; Paclitaxel; Randomized trial

Indexed keywords

CHLORPHENIRAMINE; CISPLATIN; IFOSFAMIDE; METHYLPREDNISOLONE; PACLITAXEL; RANITIDINE;

ADULT; ALOPECIA; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FATALITY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG RESPONSE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HYSTERECTOMY; ITALY; LEUKOPENIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUTROPENIA; PANCYTOPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSORY NEUROPATHY; THROMBOCYTOPENIA; URINARY TRACT INFECTION; UTERINE CERVIX CARCINOMA;

EID: 63549142273     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn690     Document Type: Article

References (11)

1. National Cancer Institute. Concurrent Chemoradiation for Cervical Cancer. Clinical Announcement. Washington DC: NCI 1999; http://www.cancer.gov/newscenter/cervicalcancer.
2. Neoadjuvant Chemotherapy for Cervical Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy locally advanced cervical cancer: A systematic review and meta-analysis of individual patient data from 21 randomised trials. Eur J Cancer 2003; 39: 2470-2486.
3. Neoadjuvant Chemotherapy for Cervical Cancer Meta-Analysis Collaboration (NACCCMA) Collaboration. Neoadjuvant chemotherapy for locally advanced cervix cancer. Cochrane Database Syst Rev 2004; (2): CD001774 Review. PMID: 15106161.
4. Buda A, Fossati R, Colombo N et al. Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: The SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study. J Clin Oncol 2005; 23(18): 4137-4145.
5. FIGO Committee on Gynecologic Oncology. Staging classifications and clinical practice guidelines of gynaecologic cancers. Int J Gynecol Obstet 2000; 70: 207-312.
6. Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 1974; 44: 265-272.
7. Therasse P, Arbuck SG, Eisenhauer EA et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92(3): 205-216.
8. Makuch RW, Simon RM. Sample size requirements for comparing time-to-failure among k treatment groups. J Chron Dis 1982; 35: 861-867.
9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
10. Parmar MKB, Machin D. Survival Analysis: A Practical Approach. Chichester, UK: John Wiley 1995.
11. Tzioras S, Pavlidis N, Paraskevaidis E, Ioannidis JP. Effects of different chemotherapy regimens on survival for advanced cervical cancer: Systematic review and meta-analysis. Cancer Treat Rev. 2007; 33(1): 24-38.